(Q51051144)

English

Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma.

scientific article published on 23 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma. (English)

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

1 reference

based on heuristic

inferred from title

author name string

Takeshi Harada

1

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

Shuji Ozaki

2

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

Asuka Oda

3

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

Shiro Fujii

4

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

Shingen Nakamura

5

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

Hirokazu Miki

6

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

Kumiko Kagawa

7

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

Kyoko Takeuchi

8

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

Toshio Matsumoto

9

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

Masahiro Abe

10

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

publication date

23 April 2013

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

International Journal of Hematology

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

97

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

6

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

743-748

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

https://scigraph.springernature.com/pub.10.1007/s12185-013-1321-0

0 references

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

Mechanism of action of lenalidomide in hematological malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

International staging system for multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

Dexamethasone synergizes with lenalidomide to inhibit multiple myeloma tumor growth, but reduces lenalidomide-induced immunomodulation of T and NK cell function

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1321-0

21 January 2018

Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23609417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine profiles in relapsed multiple myeloma patients undergoing febrile reactions to lenalidomide

1 reference

https://pubmed.ncbi.nlm.nih.gov/23609417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transient inflammatory reaction during lenalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23609417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/23609417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/23609417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-013-1321-0

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23609417

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51051144&oldid=1418435331"